Service interruption on Monday 11 July from 12:30 to 13:00: all the sites of the CCSD (HAL, EpiSciences, SciencesConf, AureHAL) will be inaccessible (network hardware connection).
Abstract : Botulinum neurotoxin (BoNT) is produced by the anaerobic, Gram-positive bacterium Clostridium botulinum. As one of the most poisonous toxins known and a potential bioterrosism agent, BoNT is characterized by a complex mode of action comprising: internalization, translocation and proteolytic cleavage of a substrate, which inhibits synaptic exocytotic transmitter release at neuro-muscular nerve endings leading to peripheral neuroparalysis of the skeletal and autonomic nervous systems. There are seven major serologically distinct toxinotypes (A-G) of BoNT which act on different substrates. Human botulism is generally caused by BoNT/A, B and E. Due to its extreme lethality and potential use as biological weapon, botulism remains a global public health concern. Vaccination against BoNT, although an effective strategy, remains undesirable due to the growing expectation around therapeutic use of BoNTs in various pathological conditions. This review focuses on the current approaches for botulism control by immunotherapy, highlighting the future challenges while the molecular underpinnings among subtypes variants and BoNT sequences found in non-clostridial species remain to be elucidated.
https://hal-pasteur.archives-ouvertes.fr/pasteur-02453849 Contributor : NADINE DELARUEConnect in order to contact the contributor Submitted on : Friday, January 24, 2020 - 9:52:00 AM Last modification on : Thursday, April 7, 2022 - 10:10:38 AM Long-term archiving on: : Saturday, April 25, 2020 - 1:09:48 PM
Christine Rasetti-Escargueil, Michel Popoff. Antibodies and Vaccines Against Botulinum Toxins: Available Measures and Novel Approaches. Toxins, MDPI, 2019, 11 (9), pp.E528. ⟨10.3390/toxins11090528⟩. ⟨pasteur-02453849⟩